Your session is about to expire
← Back to Search
Social Support for Anxiety
N/A
Recruiting
Research Sponsored by University of California, Los Angeles
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial Must have
Healthy adults aged 18 to 35
Be between 18 and 65 years old
Must not have
Current and regular use of prescription medications related to mental health disorders
Timeline
Screening 3 weeks
Treatment Varies
Follow Up same session - directly post-acquisition (approximately 5 minutes post procedure)
Awards & highlights
No Placebo-Only Group
Summary
This trial will study whether social support reminders can prevent the acquisition of fear in healthy people and those with anxiety disorders.
Who is the study for?
This study is for adults aged 18-55, including healthy individuals and those with social anxiety disorder. Healthy participants must not have any mental health disorders, while anxious participants can also have depression or PTSD. Participants should speak English fluently and cannot be on mental health medications or pregnant.
What is being tested?
Researchers at UCLA are testing if reminders of social support figures can prevent fear learning in both healthy people and those with social anxiety disorder. The test involves associating a neutral image with a mild shock in the presence of supportive images.
What are the potential side effects?
Since this trial uses non-invasive methods like images and mild electric shocks, side effects may include temporary discomfort from the shock or emotional distress related to the fear acquisition procedure.
Eligibility Criteria
Inclusion Criteria
You may be eligible if you check “Yes” for the criteria belowSelect...
I am a healthy adult between 18 and 35 years old.
Exclusion Criteria
You may be eligible for the trial if you check “No” for criteria below:Select...
I regularly take prescription medication for a mental health condition.
Timeline
Screening ~ 3 weeks3 visits
Treatment ~ Varies
Follow Up ~ during acquisition procedure
Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~during acquisition procedure
Treatment Details
Study Objectives
Study objectives can provide a clearer picture of what you can expect from a treatment.Primary study objectives
Fear response during acquisition indicated by elevated Galvanic Skin Response (GSR)
Fear response post-acquisition indicated by elevated GSR
Awards & Highlights
No Placebo-Only Group
All patients enrolled in this study will receive some form of active treatment.
Trial Design
1Treatment groups
Experimental Treatment
Group I: Social SupportExperimental Treatment1 Intervention
Find a Location
Who is running the clinical trial?
University of California, Los AngelesLead Sponsor
1,569 Previous Clinical Trials
10,314,189 Total Patients Enrolled
35 Trials studying Anxiety
38,357 Patients Enrolled for Anxiety
National Institute of Mental Health (NIMH)NIH
2,936 Previous Clinical Trials
2,741,913 Total Patients Enrolled
91 Trials studying Anxiety
41,894 Patients Enrolled for Anxiety
Media Library
Eligibility Criteria:
This trial includes the following eligibility criteria:- I am a healthy adult between 18 and 35 years old.You do not have a history of mental illness, including anxiety, depression, phobia, or any other mental health disorder diagnosed by a professional.I regularly take prescription medication for a mental health condition.I have been diagnosed with social anxiety disorder and may also have depression, other anxiety disorders, or PTSD.I am between 18 and 35 years old.I have been diagnosed with social anxiety disorder and may also have depression, other anxiety disorders, or PTSD.
Research Study Groups:
This trial has the following groups:- Group 1: Social Support
Awards:
This trial has 1 awards, including:- No Placebo-Only Group - All patients enrolled in this study will receive some form of active treatment.
Timeline:
This trial has the following timeline:- Screening: It may take up to 3 Weeks to process to see if you qualify in this trial.
- Treatment: The duration you will receive the treatment varies.
- Follow Ups: You may be asked to continue sharing information regarding the trial for 6 Months after you stop receiving the treatment.